ACS-REAL Pragmatic study (EVOLVE MI)
Research payments
$907,337
Through program year 2023, $907,337 in research payments was reported against ACS-REAL Pragmatic study (EVOLVE MI), across 32 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $880,237 | 30 |
| 2022 | Research | $27,100 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John McGinty Richmond, IN Named on 1 payment
- Matthew Cavender Chapel Hill, NC Named on 1 payment
- Thomas Nero Stamford, CT Named on 1 payment
- Michael Pursley Fairhope, AL Named on 1 payment
- Brian Nolan Meridian, ID Named on 1 payment
- Eric Yang Los Angeles, CA Named on 1 payment
- Francesco Franchi Jacksonville, FL Named on 1 payment
- Aylmer Tang Chambersburg, PA Named on 1 payment
- Christopher Cannon Boston, MA Named on 1 payment
- Anderson Mehrle Bartlesville, OK Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.